FTC Announces Settlement, Results of Operation Cure.All 2002 33809FTC Announces Settlement, Results of Operation Cure.All 2002

FTC Announces Settlement, Results of Operation Cure.All 2002

WASHINGTON--The Federal Trade Commission (FTC)announced July 24 that San Ysidro, Calif.-based BioPulse International Inc., itssubsidiaries and its directors agreed to settle FTC charges for "deceptiveacts or practices, and false advertisements." BioPulse International,BioPulse Inc. and its directors, Jonathan Neville and Loran Swenson, werecontacted by FTC regarding Insulin-Induced Hypoglycemic Sleep Therapy (IHT) andAcoustic Lightwave Therapy (ALW), both of which were touted as alternativeremedies for treating cancer and other conditions such as arthritis, diabetesand pneumonia, and had been advertised since "at least March 2001" forthese purposes.In related news, FTC announced it sent more than 200 domesticand more than 80 foreign advisory letters for "questionable claims"made on health-related Web sites regarding products or services during itsOperation Cure.All 2002 campaign (www.ftc.gov/cureall).The advisory letters alerted site operators that they must have scientificsupport for the claims they make, and reportedly, FTC and the Food and DrugAdministration (FDA) will revisit these sites to determine whether they are incompliance with FTC and FDA regulations. Appropriate regulatory and lawenforcement actions will be initiated as warranted, according to FTC.